Page last updated: 2024-08-16

rabeprazole and capecitabine

rabeprazole has been researched along with capecitabine in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
D'Antonio, C; Fais, S; Falcone, R; Marchetti, P; Milano, A; Roberto, M; Romiti, A	1
Fujita, KI; Ishida, H; Ishikawa, F; Kubota, Y; Ohkuma, R; Sasaki, Y; Sekido, M; Shibanuma, M; Takahashi, T; Tsunoda, T	1

Reviews

1 review(s) available for rabeprazole and capecitabine

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

1 trial(s) available for rabeprazole and capecitabine

Article	Year
Association Between Proton Pump Inhibitors and Metronomic Capecitabine as Salvage Treatment for Patients With Advanced Gastrointestinal Tumors: A Randomized Phase II Trial. Clinical colorectal cancer, 2016, Volume: 15, Issue:4 Topics: Administration, Metronomic; Adult; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Disease-Free Survival; Female; Gastrointestinal Neoplasms; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Proton Pump Inhibitors; Rabeprazole; Research Design; Salvage Therapy	2016

Article

Year

Association Between Proton Pump Inhibitors and Metronomic Capecitabine as Salvage Treatment for Patients With Advanced Gastrointestinal Tumors: A Randomized Phase II Trial.

Clinical colorectal cancer, 2016, Volume: 15, Issue:4

Topics: Administration, Metronomic; Adult; Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Disease-Free Survival; Female; Gastrointestinal Neoplasms; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Proton Pump Inhibitors; Rabeprazole; Research Design; Salvage Therapy

2016

Other Studies

1 other study(ies) available for rabeprazole and capecitabine

Article	Year
Rabeprazole intake does not affect systemic exposure to capecitabine and its metabolites, 5'-deoxy-5-fluorocytidine, 5'-deoxy-5-fluorouridine, and 5-fluorouracil. Cancer chemotherapy and pharmacology, 2019, Volume: 83, Issue:6 Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Capecitabine; Cell Proliferation; Chromatography, High Pressure Liquid; Colorectal Neoplasms; Deoxycytidine; Drug Interactions; Female; Floxuridine; Fluorouracil; Humans; Male; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Rabeprazole	2019

Article

Year

Rabeprazole intake does not affect systemic exposure to capecitabine and its metabolites, 5'-deoxy-5-fluorocytidine, 5'-deoxy-5-fluorouridine, and 5-fluorouracil.

Cancer chemotherapy and pharmacology, 2019, Volume: 83, Issue:6

Topics: Aged; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Capecitabine; Cell Proliferation; Chromatography, High Pressure Liquid; Colorectal Neoplasms; Deoxycytidine; Drug Interactions; Female; Floxuridine; Fluorouracil; Humans; Male; Middle Aged; Prospective Studies; Proton Pump Inhibitors; Rabeprazole

2019